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Abstract 
Purpose: To explore the effects of Carthamus tinctorius L. extract (CTLE) on diethylnitrosamine (DEN)-
induced liver cirrhosis in rats. 
Methods: CTLE was obtained by extracting the dried Carthamus tinctorius L. in water. Liver cirrhosis 
was induced by injecting the rats with DEN once a week for 8 weeks. Following this treatment, clinical 
biochemical assessments, as well as oxidative stress test and histopathological examination were 
performed. 
Results: Compared with the control group, plasma concentrations of alanine transaminase (ALT) and 
aspartate aminotransferase (AST) both decreased significantly (p < 0.01) after 8 weeks. The degree of 
liver fibrosis, cirrhosis and necrosis decreased in CTLE-treated rats. CTLE significantly inhibited 
malondialdehyde (MDA) and superoxide dismutases (SOD) in DEN-induced rat liver (p < 0.01) 
compared with control group.  
Conclusion: CTLE has significant inhibitory effect on diethylnitrosamine-induced liver cirrhosis in rats, 
which can be developed for future clinical applications. 
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Liver fibrosis is a multi-step process resulting 
from various factors such as viral hepatitis, 
alcohol abuse, biliary atresia and hepatotoxins. 
Hepatic fibrosis is associated with apoptosis of 
activated hepatic stellate cells [1]. Characteristic 
of liver cirrhosis included cell viability and redox 
ratio decrease, reactive oxygen species 
formation, lipid peroxidation, DNA fragmentation, 
and formation of apoptotic bodies, which 
provided potential targets for therapy [2]. 
Inhibition of oxidative stress provoked and 
participated in the prevention of the progression 
of liver cirrhosis [3]. It has been found that DEN-
induced liver cirrhosis in rats was similar to those 
of human cirrhosis [4,5]. 
 
Modern pharmacological experiments have 
demonstrated that Carthamus tinctorius L with its 
active compounds possesse wide-reaching 
biological activities, including dilated coronary 
artery, improved myocardial ischemia, modulated 
immune system, anticoagulation and anti-
thrombosis, anti-oxidation, anti-aging, anti-
hypoxia, anti-fatigue, anti-inflammation, anti-
hepatic fibrosis, antitumor, analgesia, etc [6-11]. 
Due to its traditional use of Carthamus tinctorius 
L in the prevention of liver cirrhosis [12], this 
study was performed on models of liver cirrhosis 
in rats. 
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The herbal samples of Carthamus tinctorius L 
were collected from Bozhou City, Anhui Province 
in China in May 2014. Taxonomic identification of 
the plant was performed by Professor Hu-lin 
Chen of Wuhan University in China. A voucher 
specimen of herbarium (no. CTL 201409024) 
was deposited in the College of Pharmacy, 
Wuhan University, China for future reference. 
The aqueous extract of CTL was obtained by 
steeping the dried Carthamus tinctorius L in 
water at 60 oC three times, each for one hour 
before first drying in an oven and then freeze-
drying the last extract thus obtained. One gram 
powder was equivalent to about 1.8 g crude 




Male Wistar rats weighing 180 – 220 g were 
provided by the Experimental Animal Center of 
Hubei Province (Certificate no. SYXK 2007-
0003). The animals had free access to food and 
water, and were allowed to acclimatize for at 
least one week before use. The rat experiment 
was approved by the Animal Care and Use 
Committee of Wuhan University (approval ref no. 
20100906) and was carried out in compliance 
with Directive 2010/63/EU on the handling of 
animals used for scientific purposes [13]. 
 
Animal groups  
 
The rats were randomly divided into 3 groups of 
ten rats each: Group I: injected with saline 
solution and oral saline solution after saline 
injection, used as normal group). Group II: 
injected with DEN (70 mg/2 mL/kg body 
weight/rat, once a week) and oral saline solution 
after DEN treatment for 8 weeks, used as a 
positive control group (Model group). Group III: 
injected with DEN (70 mg/2 mL/kg body 
weight/rat, once a week) and oral CTLE (40 
mg/10 mL/kg body weight/rat, once every day) 




In the 4th and 8th week treatment, blood 
samples (0.5 mL) were collected into heparinized 
tubes from each rat by the puncture of the retro 
orbital sinus. Blood was immediately processed 
by centrifugation at 3500g for 15 min. Serum 
levels of alanine transaminase (ALT) and 
aspartate aminotransferase (AST) were 
measured by spectrophotometry, using 





For the histopathological examination, the liver 
tissue was fixed in 10 % formalin for paraffin 
embedding. Five-μm-thick sections were 
prepared and stained with hematoxylin and 
eosin. It was randomly cut into 6 histological 
sections. Histopathology examination was 
completed using Nikon eclipse TE2000-U 
Microscope. Masson trichrome staining was used 
to identify collagen tissues. 
 
Determination of oxidative stress parameters 
in the liver tissue 
 
Rats were sacrificed and their livers were 
excised, rapidly washed and homogenized in ten 
volumes (v/w) of ice-cold saline solution. The 
homogenate was centrifuged at 3000 rpm for 10 
min. Its supernatant was used as a total liver 
homogenized sample (10 % homogenates). The 
levels of malondialdehyde (MDA), a biomarker of 
lipid peroxidation, were determined spectropho-
tometrically by measuring thiobarbituric acid 
reactive substances (TBARS). 1 mL of 10 % 
trichloroacetic acid and 1 mL of 0.67 % 
thiobarbituric acid were added to 0.2 mL of the 
10 % homogenates of the tissue samples. The 
mixtures were incubated at 100 oC for 15 min. 
After cooling and centrifugation, the supernatant 
was aspirated and its absorbance at 532 (A532) 
and 600 nm (A600) determined using water 
blank. MDA concentration (μmol/L) was 
computed according to the reference [14]. SOD 
activity was measured by spectrophotometry, 
using commercially available SOD kit, A001-1 




Data are presented as mean ± standard 
deviation (SD) and were analyzed statistically by 
one-way ANOVA followed by Tukey’s multiple 
comparison using SPSS 16.0 software for 
Windows. Differences were considered 




Fibrosis and cirrhosis 
 
With the weekly DEN-injection, the body weight 
of rats dropped gradually. DEN administration 
induced marked increases in the activity of 
serum ALT and AST (p < 0.01) compared with 
the normal group. CTLE ameliorated the 
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increase of ALT and AST. After the 8th week 
DEN-injection, liver cirrhosis formed in the 
control and CTLE groups. Plasma concentrations 
of ALT and AST in the 8th-week control group 
significantly decreased compared with that in the 
4th-week control group (p < 0.05), but they were 
still higher than that in the normal group. 
Compared with control group,plasma 
concentrations of ALT and AST both decreased 





Blue regions in Fig 1b and c indicated a 
significant level of fibrosis in the DEN-induced 
rats. As Fig 1 shows, there were overt cirrhosis 
and nodule formation with fibrosis in DEN-
induced rats. The degrees of liver fibrosis, 
cirrhosis and necrosis were mild scattered in 
CTLE-treated rats and confluent zonal in non-
treated group. Meanwhile, scores for fatty 
infiltration were mild in CTLE group and 
moderate in control group. 
 
Effect of CTLE on MDA and SOD levels in 
liver cirrhosis rats 
 
MDA, presented statistically significantly 
increased levels in DEN-induced rats (p < 0.01). 
CTLE significantly inhibited MDA formation in 
DEN-induced rat liver (p < 0.01). Conversely, the 
levels of SOD were significantly increased in the 
livers of rats receiving CTLE administration 
compared with non-treated cirrhosis group (Table 
3). 
 
Table 3: Effect of CTLE on MDA and SOD contents in 
rat liver 
 
Group MDA (umol/L) 
SOD 
(U/mg protein) 
Normal 0.08±0.03** 0.82±0.12** 
Control 0.32±0.02 0.46±0.06 
CTLE 0.13±0.02** 0.73±0.04** 
*P < 0.05，**p < 0.01 vs. control group 
 
  Table 1: Effect of CTLE on serum ALT (U/L) 
 
Groups 0 week 4 weeks 8 weeks 
Normal 101.3±3.4 99.26±3.6 100.6±3.5 
Control 102.5±3.3  523.1±12.4**  238.4±9.6* 
CTLE 102.8±3.4 152.6±5.7△△ 137.3±4.4△△ 
     *P < 0.05，**p < 0.01 vs. normal group; △p < 0.05，△△p < 0.01 vs. control group 
 
  Table 2: Effect of CTLE on serum AST (U/L) 
 
Groups 0 week 4 weeks 8 weeks 
Normal 108.6±4.2 104.4±3.8 106.1±3.2 
Control 106.4±4.5  347.6±10.4** 198.5±5.3* 
CTLE 101.5±4.7 134.7±6.2△△ 152.1±3.4△△ 
    *P < 0.05，**p < 0.01 vs. normal group; △p < 0.05，△△p < 0.01 vs. control group 
 
 
   
Fig 1: Masson trichrome histological slides of rat liver tissues. a: normal group; b: control group; c: CTLE 




Recently, many researchers have focused on the 
anti-fibrosis properties of herb medicines.In our 
research, oral administration of CTLE showed 
improvement in liver fibrosis and cirrhosis 
induced by DEN. The mechanisms that 
participated in the induction of the fibrotic 
process include necrosis, apoptosis [15], 
inflammatory reactions and the activation of 
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hepatic stellate cells [16]. MDA, as an end 
product of lipid peroxidation, significantly 
increased in DEN-induced liver cirrhosis in rats 
[17]. CTLE remarkably inhibited MDA formation 
and increase the enzyme activity of SOD in DEN-
induced rats. CTLE inhibited DEN-induced 
fibrosis process through the anti-oxidant activity. 
CTLE reduced the extent of DNA damage and 
serum levels of ALT and AST at the 4th and the 
8th weeks compared with non-treated DEN-
induced rats. All these demonstrated that CTLE 
participated in the attenuation of apoptosis, 
oxidative stress and DNA fragment in fibrotic 
liver. CTLE may be a potential antifibrotic agent 
in the future. 
 
In the present study, CTLE was effective in the 
treatment of chemically induced liver fibrosis in 
rats. Their anti-fibrosis mechanisms that 
participated in the inhibition of the fibrotic 
process included anti-oxidant, anti-apoptosis, 
and metabolic disturbance in DEN-induced liver 




CTLE has significant inhibitory effect on 
diethylnitrosamine-induced liver cirrhosis in rats, 
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